1. Home
  2. RRX vs KRYS Comparison

RRX vs KRYS Comparison

Compare RRX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regal Rexnord Corporation

RRX

Regal Rexnord Corporation

HOLD

Current Price

$209.28

Market Cap

13.6B

Sector

N/A

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$266.32

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRX
KRYS
Founded
1955
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
7.8B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
RRX
KRYS
Price
$209.28
$266.32
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$209.70
$297.60
AVG Volume (30 Days)
941.2K
223.8K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.67%
N/A
EPS Growth
42.86
128.00
EPS
4.20
6.84
Revenue
$3,257,100,000.00
$389,130,000.00
Revenue This Year
$4.15
$39.88
Revenue Next Year
$12.25
$34.38
P/E Ratio
$49.58
$37.88
Revenue Growth
5.21
33.94
52 Week Low
$94.42
$123.03
52 Week High
$229.30
$298.30

Technical Indicators

Market Signals
Indicator
RRX
KRYS
Relative Strength Index (RSI) 61.80 57.53
Support Level $136.55 $255.65
Resistance Level $227.65 $293.60
Average True Range (ATR) 8.13 9.04
MACD 3.16 1.74
Stochastic Oscillator 97.89 84.13

Price Performance

Historical Comparison
RRX
KRYS

About RRX Regal Rexnord Corporation

Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: